Published in J Neurochem on December 01, 1961
Electron microscope localization of acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat. I. Normal ganglion. J Cell Biol (1978) 1.13
Protein synthesis in the isolated giant axon of the squid. Proc Natl Acad Sci U S A (1968) 0.96
ACETYLCHOLINESTERASE IN FROG SYMPATHETIC AND DORSAL ROOT GANGLIA : A Study by Electron Microscope Cytochemistry and Microgasometric Analysis with the Magnetic Diver. J Cell Biol (1966) 0.92
ELECTROPHORETIC PRODUCTION OF "REACTIVE" AXON SWELLINGS IN VITRO AND THEIR HISTOCHEMICAL PROPERTIES. Acta Neuropathol (1964) 0.90
Rapid orthograde and retrograde axonal transport of acetylcholinesterase as characterized by the stop-flow technique. J Physiol (1978) 0.85
The appearance of acetylcholinesterase in the dorsal root neuroblast of the rabbit embryo. A study by electron microscope cytochemistry and microgasometric analysis with the magnetic diver. J Cell Biol (1970) 0.82
The histochemical identification of acetylcholinesterase in cholinergic, adrenergic and sensory neurons. J Pharmacol Exp Ther (1955) 5.42
The elimination of enzymatic diffusion artifacts in the histochemical localization of cholinesterases and a survey of their cellular distributions. J Pharmacol Exp Ther (1951) 5.23
The histochemical differentiation of types of cholinesterases and their localizations in tissues of the cat. J Pharmacol Exp Ther (1950) 4.80
The histochemical localization of cholinesterases in the central nervous system of the rat. J Comp Neurol (1954) 2.74
A histochemical method for localizing cholinesterase activity. Proc Soc Exp Biol Med (1949) 2.66
The distribution cholinesterases in human skin, with special reference to eccrine and apocrine sweat glands. J Invest Dermatol (1953) 2.13
The physiological role of acetyl-cholinesterase (AChE) in sympathetic ganglia. J Pharmacol Exp Ther (1961) 1.99
A new general concept of the neurohumoral functions of acetylcholine and acetylcholinesterase. J Pharm Pharmacol (1962) 1.86
The cerebral distributions of a tertiary and a quaternary anticholinesterase agent following intravenous and intraventricular injection. J Pharmacol Exp Ther (1956) 1.82
The effect of inhibition of specific and non-specific cholinesterase on the motility of the isolated ileum. J Pharmacol Exp Ther (1950) 1.82
A proposed dual neurohumoral role of acetylcholine: its functions at the pre- and post-synaptic sites. Nature (1961) 1.71
Congenital megacolon; a comparison of the spastic and hypertrophied segments with respect to Cholinesterase activities and sensitivities to Acetylcholine, DFP and the barium ion. Gastroenterology (1953) 1.68
HISTOCHEMICAL CORRELATIONS OF ACETYLCHOLINESTERASE AND CATECHOLAMINES IN POSTGANGLIONIC AUTONOMIC NERVES OF THE CAT, RABBIT, AND GUINEA PIG. J Pharmacol Exp Ther (1965) 1.67
The action of antihistaminics and atropine in blocking the spasmogenic activity of serotonin on the guinea pig ileum. Arch Int Pharmacodyn Ther (1953) 1.59
The localization of external or functional acetylcholinesterase at the synapses of autonomic ganglia. J Pharmacol Exp Ther (1959) 1.58
Cholinesterases of the tissues and sera of rabbits. Biochem J (1953) 1.50
A histochemical study of cholinesterase during formation of the motor end plate of the albino rat. J Exp Zool (1951) 1.44
Comparison of the effects of inhibition of external, internal and total acetylcholinesterase upon ganglionic transmission. J Pharmacol Exp Ther (1959) 1.42
The histochemical localization of cholinesterase in ocular tissues. Am J Ophthalmol (1950) 1.27
A possible enzymatic basis for the differential action of mydriatics on light and dark irides. J Physiol (1953) 1.23
Modification of the effects of sympathomimetic amines and of adrenergic nerve stimulation by 1-isonicotinyl-2-isopyropylhydrazine (IIH) and isonicotinic acid hydrazide (INH). J Pharmacol Exp Ther (1956) 1.15
Histochemical demonstration of cholinesterases in the hypothalamus of the dog. J Physiol (1957) 1.13
Localization of acetylcholinesterase in the neurohypophysis and its functional implications. Proc Soc Exp Biol Med (1961) 1.11
Enhancement of inhibitory and excitatory effects of catecholamines. J Pharmacol Exp Ther (1960) 1.09
SYNTHETIC MECHANISMS IN THE AXON. I. LOCAL AXONAL SYNTHESIS OF ACETYLCHOLINESTERASE. J Neurochem (1965) 1.09
The relationship between cholinesterase inhibition and ganglionic transmission. J Pharmacol Exp Ther (1952) 1.08
SYNTHETIC MECHANISMS IN THE AXON. II. RNA IN MYELIN-FREE AXONS OF THE CAT. J Neurochem (1965) 1.05
Localization of specific cholinesterase in ocular tissues of the cat. Am J Ophthalmol (1952) 1.02
The nature of synaptic transmission in the superior cervical ganglion following reinnervation by the afferent vagus. J Pharmacol Exp Ther (1961) 1.01
Histochemical demonstration of reactivation acetylcholinesterase in vivo. Science (1957) 0.94
ELECTRON MICROSCOPIC LOCALIZATION OF CHOLINESTERASES IN A SYMPATHETIC GANGLION BY A GOLD-THIOLACETIC ACID METHOD. Life Sci (1965) 0.93
Histochemical demonstration of reversible anticholinesterase action at selective cellular sites in vivo. J Pharmacol Exp Ther (1957) 0.93
The cytological localization of intracellular neuronal acetylcholinesterase. J Biophys Biochem Cytol (1959) 0.92
2-Amino-5-chlorobenzoxazole (McN-485, flexin), a long-acting spinal cord depressant. Proc Soc Exp Biol Med (1955) 0.88
Physiological implications of the histochemical localization of monoamine oxidase. J Physiol (1954) 0.88
THE RELEASE OF ACETYLCHOLINE FROM A SYMPATHETIC GANGLION BY CARBACHOL. RELATIONSHIP TO THE FUNCTIONAL SIGNIFICANCE OF THE LOCALIZATION OF ACETYLCHOLINESTERASE. Can J Biochem Physiol (1963) 0.87
Histochemical demonstration of monoamine oxidase in human skin. J Invest Dermatol (1955) 0.86
Facilitation of ganglionic transmission following inhibition of cholinesterase by DFP. J Pharmacol Exp Ther (1954) 0.85
The adrenochrome redox system. Arch Biochem Biophys (1951) 0.84
The destruction of epinephrine by the DOPA-oxidase system of ocular tissue. Science (1952) 0.84
A QUANTITATIVE MICRO METHOD FOR DETERMINATION OF SPECIFIC RADIOACTIVITIES OF H3-PURINES AND H3-PYRIMIDINES. Anal Biochem (1963) 0.84
The effect of inhibition of non-specific cholinesterase on perception of tactile sensation in human volar skin. J Invest Dermatol (1958) 0.80
Production in vitro of melanin-like pigmentation by cells of the intestinal mucosa. Experientia (1958) 0.78
The effects of auditory pathway interruption on the incidence of sound-induced seizures in rats. J Comp Neurol (1957) 0.78
The use of histochemistry in pharmacological studies. Biochem Pharmacol (1962) 0.78
Reactivation of DFP-inactivated acetylcholinesterase by monoisonitrosoacetone (MINA) and diacetylmonoxime (DAM) in vivo. J Pharmacol Exp Ther (1958) 0.78
[Diabetes occurring during the delta-cortisone therapy of cirrhosis]. Rev Med Nancy (1959) 0.78
Acetylcholinesterase regeneration in peripheral nerve after irreversible inactivation. Science (1960) 0.78
The relationship between cholinesterase inhibition and the pharmacological action of di-isopropyl fluorophosphate (DFP). J Pharmacol Exp Ther (1946) 0.77
Possible mechanisms for the termination of the physiological actions of catecholamines. Pharmacol Rev (1959) 0.77
Anticholinesterase drugs. J Pharmacol Exp Ther (1949) 0.75
Protection of cholinesterase against irreversible inactivation by di-isopropyl fluorophosphate in vitro. J Pharmacol Exp Ther (1946) 0.75
[The pitch discrimination threshold and its relation to the intensity discrimination threshold from the clinical viewpoint]. Arch Ohren Nasen Kehlkopfheilkd (1961) 0.75
Cardiovascular and oxytocic actions of a series of quinoline derivatives. J Pharmacol Exp Ther (1954) 0.75
Nerve conduction in the absence of cholinesterase activity induced by di-isopropyl fluorophosphate. Fed Proc (1946) 0.75
The effect of single intravenous and oral doses of McN-181 (1,4-bis (1,4-benzodioxan-2-ylmethyl) piperazine) upon the blood pressure of hypertensive subjects. Am J Med Sci (1954) 0.75
Cholinesterases of the central nervous system. J Neuropathol Exp Neurol (1955) 0.75
The chronic toxicity of di-isopropyl fluorophosphate (DFP) in dogs, monkeys and rats. J Pharmacol Exp Ther (1946) 0.75
[CLINICO-EXPERIMENTAL STUDIES ON THE POSITIVE INOTROPIC EFFECT OF PERSANTIN]. Med Klin (1964) 0.75
[Secondary gout in ostiomyelosclerosis and polycythemia vera]. Med Klin (1962) 0.75
Pharmacological approaches to the study of tranquilizing agents. Psychiatr Res Rep Am Psychiatr Assoc (1958) 0.75
[Physiological and pharmacological significance of cholinesterase and anticholinesterase]. Klin Wochenschr (1958) 0.75
FROM THE LINTEL. Am J Pharm Sci Support Public Health (1965) 0.75
The chronic toxicity of di-isopropyl fluorophosphate in dogs, monkeys and rats. Fed Proc (1946) 0.75
Structure of the motor endplate. Am J Med (1955) 0.75
[On yeast aldolase]. Hoppe Seylers Z Physiol Chem (1961) 0.75
Transmission of impulses in peripheral nerves treated with di-isopropyl fluorphosphate. J Neurophysiol (1946) 0.75
The localization of specific cholinesterase in the retina. Pharmacol Rev (1954) 0.75
[Television for audiometric purposes]. HNO (1962) 0.75
[An alpha-myeloma with retothelial tumor formation]. Acta Haematol (1960) 0.75
The effects of intravenous infusions of the optical isomers of dibozane (McN-181;1,4-bis[1,4-benzodioxan-2-ylmethyl] piperazine), an adrenergic blocking agent, upon hypertensive subjects. Am J Med Sci (1954) 0.75
The histochemical differentiation of types of cholinesterase and their distributions in the tissues of the cat. Bull Johns Hopkins Hosp (1950) 0.75
The treatment of di-isopropyl fluorophosphate (DFP) poisoning in rabbits. J Pharmacol Exp Ther (1946) 0.75
The localizanon or acetylcholinesterase in neurons. Prog Neurobiol (1957) 0.75
The pharmacology of di-isopropyl fluorophosphate in man. J Pharmacol Exp Ther (1946) 0.75
[CONGENITAL NONSPHEROCYTIC HEMOLYTIC ANEMIA IN FAMILIAL DPNH AND TPNH-DEPENDENT GLUTATHIONE REDUCTASE DEFICIENCY OF THE ERYTHROCYTES. I]. Klin Wochenschr (1965) 0.75
Pharmacologic significance of inhibition of monomine oxidase. J Clin Exp Psychopathol (1958) 0.75
The coming of age of therapeutics. Am J Pharm Sci Support Public Health (1963) 0.75
The cardiovascular and respiratory actions of rauwolscine. J Pharmacol Exp Ther (1958) 0.75
The pharmacology of mescaline and D-lysergic acid diethylamide (LSD). N Engl J Med (1958) 0.75
[Changes in plasma volume during and after physical work in right-sided insufficiency of the heart]. Verh Dtsch Ges Kreislaufforsch (1961) 0.75
The acute toxicity of di-isopropyl fluorophosphate. J Pharmacol Exp Ther (1946) 0.75
[The course of enzymatic and histological changes in the rat kidney after a single dose of tetrachloride poisoning]. Z Gesamte Exp Med (1960) 0.75
Current concepts in the management of functional gastrointestinal disorders; transcription of a panel meeting on therapeutics. Bull N Y Acad Med (1954) 0.75